149 related articles for article (PubMed ID: 35278373)
1. Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium.
Israr MZ; Zhan H; Salzano A; Voors AA; Cleland JG; Anker SD; Metra M; van Veldhuisen DJ; Lang CC; Zannad F; Samani NJ; Ng LL; Suzuki T;
Am Heart J; 2022 Jun; 248():108-119. PubMed ID: 35278373
[TBL] [Abstract][Full Text] [Related]
2. Association of gut-related metabolites with outcome in acute heart failure.
Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
[TBL] [Abstract][Full Text] [Related]
3. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
4. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF.
Suzuki T; Yazaki Y; Voors AA; Jones DJL; Chan DCS; Anker SD; Cleland JG; Dickstein K; Filippatos G; Hillege HL; Lang CC; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M; Ng LL
Eur J Heart Fail; 2019 Jul; 21(7):877-886. PubMed ID: 30370976
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
6. Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort.
Wargny M; Croyal M; Ragot S; Gand E; Jacobi D; Trochu JN; Prieur X; Le May C; Goronflot T; Cariou B; Saulnier PJ; Hadjadj S;
Cardiovasc Diabetol; 2022 Jun; 21(1):101. PubMed ID: 35681209
[TBL] [Abstract][Full Text] [Related]
7. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
[TBL] [Abstract][Full Text] [Related]
8. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
[TBL] [Abstract][Full Text] [Related]
9. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.
Fretts AM; Hazen SL; Jensen P; Budoff M; Sitlani CM; Wang M; de Oliveira Otto MC; DiDonato JA; Lee Y; Psaty BM; Siscovick DS; Sotoodehnia N; Tang WHW; Lai H; Lemaitre RN; Mozaffarian D
JAMA Netw Open; 2022 May; 5(5):e2213242. PubMed ID: 35594043
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction.
Curran FM; Bhalraam U; Mohan M; Singh JS; Anker SD; Dickstein K; Doney AS; Filippatos G; George J; Metra M; Ng LL; Palmer CN; Samani NJ; van Veldhuisen DJ; Voors AA; Lang CC; Mordi IR
ESC Heart Fail; 2021 Aug; 8(4):3168-3179. PubMed ID: 33998162
[TBL] [Abstract][Full Text] [Related]
11. A pilot study investigating circulating trimethylamine N-oxide and its precursors in dogs with degenerative mitral valve disease with or without congestive heart failure.
Karlin ET; Rush JE; Freeman LM
J Vet Intern Med; 2019 Jan; 33(1):46-53. PubMed ID: 30511765
[TBL] [Abstract][Full Text] [Related]
12. Trimethylamine N-oxide and prognosis in acute heart failure.
Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
[TBL] [Abstract][Full Text] [Related]
13. Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
Guo F; Dai Q; Zeng X; Liu Y; Tan Z; Zhang H; Ouyang D
Int Urol Nephrol; 2021 Mar; 53(3):539-551. PubMed ID: 32945995
[TBL] [Abstract][Full Text] [Related]
14. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota.
Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA
Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200
[TBL] [Abstract][Full Text] [Related]
15. Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
Emoto T; Hayashi T; Tabata T; Yamashita T; Watanabe H; Takahashi T; Gotoh Y; Kami K; Yoshida N; Saito Y; Tanaka H; Matsumoto K; Hayashi T; Yamada T; Hirata KI
Int J Cardiol; 2021 Sep; 338():138-142. PubMed ID: 34102245
[TBL] [Abstract][Full Text] [Related]
16. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Cardiol Clin; 2022 May; 40(2):161-169. PubMed ID: 35465890
[TBL] [Abstract][Full Text] [Related]
17. FMO3-TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction: evidence from an Asian population.
Wei H; Zhao M; Huang M; Li C; Gao J; Yu T; Zhang Q; Shen X; Ji L; Ni L; Zhao C; Wang Z; Dong E; Zheng L; Wang DW
Front Med; 2022 Apr; 16(2):295-305. PubMed ID: 34159537
[TBL] [Abstract][Full Text] [Related]
18. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
[TBL] [Abstract][Full Text] [Related]
19. Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.
Papandreou C; Bulló M; Hernández-Alonso P; Ruiz-Canela M; Li J; Guasch-Ferré M; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Alonso-Gómez A; Fiol M; Santos-Lozano JM; Serra-Majem L; Liang L; Martínez-González MA; Hu FB; Salas-Salvadó J
Clin Chem; 2021 Jan; 67(1):288-297. PubMed ID: 33257943
[TBL] [Abstract][Full Text] [Related]
20. Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF Studies.
Grote Beverborg N; van der Wal HH; Klip IT; Anker SD; Cleland J; Dickstein K; van Veldhuisen DJ; Voors AA; van der Meer P
JAMA Cardiol; 2019 Jul; 4(7):696-701. PubMed ID: 31188392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
